(Q36522082)

14 August 2017

Rituximab in post-transplant pediatric recurrent focal segmental glomerulosclerosis (English)

1 reference

focal segmental glomerulosclerosis

14 August 2017

1 reference

1 reference

Robert P Woroniecki

4

0 references

author name string

Juhi Kumar

1

1 reference

14 August 2017

Ibrahim F Shatat

2

1 reference

14 August 2017

Amy L Skversky

3

1 reference

14 August 2017

Marcela Del Rio

5

1 reference

14 August 2017

Eduardo M Perelstein

6

1 reference

14 August 2017

Valerie L Johnson

7

1 reference

14 August 2017

Shefali Mahesh

8

1 reference

14 August 2017

4 October 2012

1 reference

14 August 2017

1 reference

14 August 2017

28

1 reference

14 August 2017

2

1 reference

14 August 2017

333-338

1 reference

The factors that may predict response to rituximab therapy in recurrent focal segmental glomerulosclerosis: a systematic review

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541458

Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541458

Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541458

Treatment of recurrent focal segmental glomerulosclerosis in pediatric kidney transplant recipients: effect of rituximab.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541458

Recurrent focal segmental glomerulosclerosis in the renal allograft: single center experience in the era of modern immunosuppression

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541458

Recurrence of focal segmental glomerulosclerosis in renal allograft: an in-depth review

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541458

Rituximab (B-cell depleting antibody) associated lung injury (RALI): a pediatric case and systematic review of the literature.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541458

Rituximab in minimal change nephropathy and focal segmental glomerulosclerosis: report of four cases and review of the literature.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541458

Twenty-one-year trend in ESRD due to focal segmental glomerulosclerosis in the United States

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541458

Outcomes after renal transplantation for FSGS in children

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541458

Change of the course of steroid-dependent nephrotic syndrome after rituximab therapy

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541458

Cryptogenic organizing pneumonia after rituximab therapy for presumed post-kidney transplant lymphoproliferative disease.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541458

Recurrent focal segmental glomerulosclerosis in pediatric renal transplant recipients: successful treatment with oral cyclophosphamide.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541458

Incidence, treatment, and outcome of recurrent focal segmental glomerulosclerosis posttransplantation in 42 allografts in children--a single-center experience.

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541458

Cytomegalovirus colitis and hypo-IgG after rituximab therapy for rheumatoid arthritis

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541458

Combination treatment with plasmapheresis and rituximab for recurrent focal segmental glomerulosclerosis after renal transplantation

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541458

Effect of a triple blockade of the renin-angiotensin-system in recurrent focal segmental glomerulosclerosis after kidney transplantation.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541458

Fatal pulmonary fibrosis after rituximab administration

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541458

Kidney transplantation for primary focal segmental glomerulosclerosis: outcomes and response to therapy for recurrence.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541458

Rituximab for post-transplant recurrences of FSGS.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541458

Demographics and response to therapeutic plasma exchange in pediatric renal transplantation for focal glomerulosclerosis: a single center experience

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541458

Rituximab failed to improve nephrotic syndrome in renal transplant patients with recurrent focal segmental glomerulosclerosis

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541458

Rituximab for refractory focal segmental glomerulosclerosis

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541458

Immunoadsorbtion and rituximab therapy in a second living-related kidney transplant patient with recurrent focal segmental glomerulosclerosis

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541458

High-dose oral cyclosporin therapy for recurrent focal segmental glomerulosclerosis in children

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541458

Single-center analysis of early recurrence of nephrotic syndrome following renal transplantation in children

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3541458

Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome induced by cidofovir.

21 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00467-012-2314-6

Prediction and treatment of recurrent focal segmental glomerulosclerosis after renal transplantation in children

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00467-012-2314-6

Rituximab treatment for posttransplant lymphoproliferative disorder (PTLD) induces complete remission of recurrent nephrotic syndrome

21 January 2018

1 reference

12 December 2020

Recurrence of focal segmental glomerulosclerosis posttransplantation: a special report of the North American Pediatric Renal Transplant Cooperative Study

1 reference

12 December 2020

Abrogation of nephrotic proteinuria by rituximab treatment in a renal transplant patient with relapsed focal segmental glomerulosclerosis

1 reference

12 December 2020

Severe respiratory adverse events associated with rituximab infusion

1 reference

12 December 2020

Antihuman immunoglobulin affinity immunoadsorption strongly decreases proteinuria in patients with relapsing nephrotic syndrome

1 reference

12 December 2020

Protocol biopsies for focal segmental glomerulosclerosis treated with plasma exchange and rituximab in a renal transplant patient

1 reference

12 December 2020

Long-term effect of rituximab in maintaining remission of recurrent and plasmapheresis-dependent nephrotic syndrome post-renal transplantation - case report

1 reference

12 December 2020

Rapid development of infusion-related severe hypotension during rituximab therapy

1 reference

12 December 2020

Use of Rituximab in Focal Glomerulosclerosis Relapses After Renal Transplantation

1 reference

12 December 2020

Treatment of focal segmental glomerular sclerosis with rituximab: 2 case reports

1 reference

12 December 2020

Loss of living donor renal allograft survival advantage in children with focal segmental glomerulosclerosis

1 reference

12 December 2020

Rituximab and chronic plasmapheresis therapy of nephrotic syndrome in renal transplantation patients with recurrent focal segmental glomerulosclerosis

1 reference

12 December 2020

Post-transplant focal segmental glomerulosclerosis refractory to plasmapheresis and rituximab therapy

1 reference

12 December 2020

Does rituximab treat recurrent focal segmental glomerulosclerosis post-renal transplantation?

1 reference

12 December 2020

Early use of plasmapheresis for recurrent post-transplant FSGS

1 reference

12 December 2020

Resolution of recurrent focal segmental glomerulosclerosis proteinuria after rituximab treatment

1 reference

12 December 2020

Increased nitric oxide production by T- and B-cells in idiopathic nephrotic syndrome

1 reference

12 December 2020

Successful treatment of recurrent focal segmental glomerulosclerosis after kidney transplantation by plasmapheresis and rituximab

1 reference

12 December 2020

Rituximab therapy in early recurrent focal segmental sclerosis after renal transplantation

1 reference

12 December 2020

10.1007/S00467-012-2314-6

Identifiers

DOI

1 reference

14 August 2017

1 reference

14 August 2017

PubMed publication ID

23052653

1 reference